MSK1 (phospho Ser212) Polyclonal Antibody

货号：ES7999
价格：面议
点击：2084

产品介绍

抗体信息

应用	WB;IHC-p;IF(paraffin section);ELISA
反应种属	Human;Mouse
别称	RPS6KA5; MSK1; Ribosomal protein S6 kinase alpha-5; S6K-alpha-5; 90 kDa ribosomal protein S6 kinase 5; Nuclear mitogen- and stress-activated protein kinase 1; RSK-like protein kinase; RSKL

【仅供科学研究使用】

相关产品:

产品名称	点击数
Anti-Daclizumab Neutralizing Recombinant Antibody \|抗达克珠单抗中和重组抗体(靶标：达克珠单抗中和抗体)	446
Anti-Daclizumab Neutralizing Recombinant Antibody \|抗达克珠单抗中和重组抗体(靶标：达克珠单抗中和抗体)	543
Anti-Daclizumab Neutralizing Recombinant Antibody \|抗达克珠单抗中和重组抗体(靶标：达克珠单抗中和抗体)	381
Anti-Daclizumab Neutralizing Recombinant Antibody \|抗达克珠单抗中和重组抗体(靶标：达克珠单抗中和抗体)	513
Anti-Atibuclimab Neutralizing Recombinant Antibody \|抗阿替布利单抗中和重组抗体(靶标：阿替布利单抗中和抗体)	396
Anti-Atibuclimab Neutralizing Recombinant Antibody \|抗阿替布利单抗中和重组抗体(靶标：阿替布利单抗中和抗体)	484
Anti-Atibuclimab Neutralizing Recombinant Antibody \|抗阿替布利单抗中和重组抗体(靶标：阿替布利单抗中和抗体)	237
Anti-Atibuclimab Neutralizing Recombinant Antibody \|抗阿替布利单抗中和重组抗体(靶标：阿替布利单抗中和抗体)	299
Anti-Secukinumab Neutralizing Recombinant Antibody \|抗司库奇尤单抗中和重组抗体(靶标：司库奇尤单抗中和抗体)	256
Anti-Secukinumab Neutralizing Recombinant Antibody \|抗司库奇尤单抗中和重组抗体(靶标：司库奇尤单抗中和抗体)	458
Anti-Secukinumab Neutralizing Recombinant Antibody \|抗司库奇尤单抗中和重组抗体(靶标：司库奇尤单抗中和抗体)	573
Anti-Secukinumab Neutralizing Recombinant Antibody \|抗司库奇尤单抗中和重组抗体(靶标：司库奇尤单抗中和抗体)	390
Anti-Enfortumab Neutralizing Recombinant Antibody \|抗恩福妥单抗中和重组抗体(靶标：恩福妥单抗中和抗体)	382
Anti-Enfortumab Neutralizing Recombinant Antibody \|抗恩福妥单抗中和重组抗体(靶标：恩福妥单抗中和抗体)	578
Anti-Enfortumab Neutralizing Recombinant Antibody \|抗恩福妥单抗中和重组抗体(靶标：恩福妥单抗中和抗体)	598
Anti-Enfortumab Neutralizing Recombinant Antibody \|抗恩福妥单抗中和重组抗体(靶标：恩福妥单抗中和抗体)	428
Anti-Certolizumab Non-Neutralizing Recombinant Antibody \|抗赛妥珠单抗非中和重组抗体(靶标：赛妥珠单抗非中和抗体)	256
Anti-Certolizumab Non-Neutralizing Recombinant Antibody \|抗赛妥珠单抗非中和重组抗体(靶标：赛妥珠单抗非中和抗体)	574
Anti-Certolizumab Non-Neutralizing Recombinant Antibody \|抗赛妥珠单抗非中和重组抗体(靶标：赛妥珠单抗非中和抗体)	466
Anti-Certolizumab Neutralizing Recombinant Antibody \|抗赛妥珠单抗中和重组抗体(靶标：赛妥珠单抗中和抗体)	276